Skip to main content
Passa alla visualizzazione normale.


Pari opportunità

LYDIA GIANNITRAPANI

Italy GIDEON final analysis Sorafenib-treated patients: prognostic value of baseline characteristics and staging systems

  • Authors: D'Angelo, S; Lorusso, V; Piras, MR; Sansonno, D; Giannitrapani, L; Benedetti, A; Montesarchio, V; Attili, AF; Frustaci, S; Barni, S; Pirisi, M; Carpani, D; Magini, G; Daniele, B
  • Publication year: 2014
  • Type: eedings
  • Key words: HCC; Sorafenib; clinical practice
  • OA Link: http://hdl.handle.net/10447/132552